Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01502033 · ClinicalTrials.gov registry record · NA

Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed Teens

A NA study of Major Depressive Disorder, sponsored by Paul E. Croarkin.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT01502033 is a NA study of Major Depressive Disorder that has completed, run by Paul E. Croarkin. The registered enrollment target is 10 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01502033, a NA study of Major Depressive Disorder, has completed, sponsored by Paul E. Croarkin.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This research study aims to test the safety and effectiveness of repetitive transcranial magnetic stimulation (rTMS) on teens with depression. The study also seeks to understand how rTMS treatment affects the neurobiology of teens with depression.

Conditions Studied

Interventions

  • DEVICE Transcranial Magnetic Stimulation

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2011-12
Est. Completion 2013-12
Phase NA

Sponsor

Paul E. Croarkin

3 total trials

What the Registry Record Tells You About NCT01502033

The ClinicalTrials.gov registry entry for NCT01502033 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (97% lower). The listed sponsor is Paul E. Croarkin, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.

NCT01502033 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT01502033 about?

NCT01502033 is a clinical study titled "Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed Teens". This research study aims to test the safety and effectiveness of repetitive transcranial magnetic stimulation (rTMS) on teens with depression. The study also seeks to understand how rTMS treatment affects the neurobiology of teens with depression.

What is the current status of trial NCT01502033?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2011-12. Estimated completion is 2013-12.

What conditions does trial NCT01502033 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT01502033?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT01502033?

This trial is sponsored by Paul E. Croarkin, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01502033 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.